|
|
Prepublished online as a Blood First Edition Paper on October 24, 2002; DOI 10.1182/blood-2002-07-2006.
Previous Article | Table of Contents | Next Article 
Blood, 1 March 2003, Vol. 101, No. 5, pp. 1996-2000
RED CELLS
Mitochondrial ferritin expression in erythroid cells
from patients with sideroblastic anemia
Mario Cazzola,
Rosangela Invernizzi,
Gaetano Bergamaschi,
Sonia Levi,
Barbara Corsi,
Erica Travaglino,
Valeria Rolandi,
Giorgio Biasiotto,
Jim Drysdale, and
Paolo Arosio
From the Department of Hematology and Department of
Internal Medicine and Medical Therapy, University of Pavia Medical
School and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)
Policlinico S Matteo, Pavia, Italy; Protein Engineering
Unit, DIBIT IRCCS S Raffaele Hospital, Milan, Italy;
Department of Pediatrics and Biomedical Technology, University of
Brescia School of Medicine, Brescia, Italy; and Department
of Biochemistry, Tufts University School of Medicine, Boston, MA.
The sideroblastic anemias are characterized by ring
sideroblasts, that is, red cell precursors with mitochondrial iron
accumulation. We therefore studied the expression of mitochondrial
ferritin (MtF) in these conditions. Erythroid cells from 13 patients
with refractory anemia with ring sideroblasts (RARS) and 3 patients with X-linked sideroblastic anemia (XLSA) were analyzed for the distribution of cytoplasmic H ferritin (HF) and MtF using
immunocytochemical methods. We also studied 11 healthy controls, 5 patients with refractory anemia without ring sideroblasts (RA), and 7 patients with RA with excess of blasts (RAEB). About one fourth of
normal immature red cells, mostly proerythroblasts and basophilic
erythroblasts, showed diffuse cytoplasmic positivity for HF, but very
few were positive for MtF (0%-10%). Similar patterns were found in
anemic patients without ring sideroblasts. In contrast, many
erythroblasts from patients with sideroblastic anemia (82%-90% in
XLSA and 36%-84% in RARS) were positive for MtF, which regularly
appeared as granules ringing the nucleus. Double immunocytochemical
staining confirmed the different cellular distribution of HF and MtF.
There was a highly significant relationship between the percentage of
MtF+ erythroblasts and that of ring sideroblasts (Spearman
R = 0.90; P < .0001). Reverse
transcription-polymerase chain reaction studies demonstrated the
presence of MtF mRNA in circulating reticulocytes of 2 patients with
XLSA but not in controls. These findings suggest that most of the iron
deposited in perinuclear mitochondria of ring sideroblasts is present
in the form of MtF and that this latter might be a specific marker of
sideroblastic anemia.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Malcovati and M. Cazzola
Myelodysplastic/myeloproliferative disorders
Haematologica,
January 1, 2008;
93(1):
4 - 6.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Santambrogio, G. Biasiotto, F. Sanvito, S. Olivieri, P. Arosio, and S. Levi
Mitochondrial Ferritin Expression in Adult Mouse Tissues
J. Histochem. Cytochem.,
November 1, 2007;
55(11):
1129 - 1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Cavadini, G. Biasiotto, M. Poli, S. Levi, R. Verardi, I. Zanella, M. Derosas, R. Ingrassia, M. Corrado, and P. Arosio
RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload
Blood,
April 15, 2007;
109(8):
3552 - 3559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Richardson and D. B. Lovejoy
"Iron mining" to inhibit tumor growth
Blood,
October 1, 2006;
108(7):
2140 - 2140.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Nie, G. Chen, A. D. Sheftel, K. Pantopoulos, and P. Ponka
In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin
Blood,
October 1, 2006;
108(7):
2428 - 2434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pellagatti, M. Cazzola, A. A. N. Giagounidis, L. Malcovati, M. G. D. Porta, S. Killick, L. J. Campbell, L. Wang, C. F. Langford, C. Fidler, et al.
Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype
Blood,
July 1, 2006;
108(1):
337 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Nakajima, S. Okano, H. Harada, T. Kusaka, X. Gao, T. Hosoya, N. Suzuki, S. Takahashi, and M. Yamamoto
Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes
Genes Cells,
June 1, 2006;
11(6):
685 - 700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Missirlis, S. Holmberg, T. Georgieva, B. C. Dunkov, T. A. Rouault, and J. H. Law
Characterization of mitochondrial ferritin in Drosophila
PNAS,
April 11, 2006;
103(15):
5893 - 5898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Iwasaki, E. L. MacKenzie, K. Hailemariam, K. Sakamoto, and Y. Tsuji
Hemin-Mediated Regulation of an Antioxidant-Responsive Element of the Human Ferritin H Gene and Role of Ref-1 during Erythroid Differentiation of K562 Cells.
Mol. Cell. Biol.,
April 1, 2006;
26(7):
2845 - 2856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Donovan, C. N. Roy, and N. C. Andrews
The Ins and Outs of Iron Homeostasis
Physiology,
April 1, 2006;
21(2):
115 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Della Porta, L. Malcovati, A. Galli, S. Boggi, E. Travaglino, C. Marseglia, M. Maffioli, S. Levi, P. Arosio, R. Invernizzi, et al.
Mitochondrial Ferritin Expression and Clonality of Hematopoiesis in Patients with Refractory Anemia with Ringed Sideroblasts.
Blood (ASH Annual Meeting Abstracts),
November 16, 2005;
106(11):
3444 - 3444.
[Abstract]
|
 |
|

|
 |

|
 |
 
R. Tehranchi, R. Invernizzi, A. Grandien, B. Zhivotovsky, B. Fadeel, A.-M. Forsblom, E. Travaglino, J. Samuelsson, R. Hast, L. Nilsson, et al.
Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes
Blood,
July 1, 2005;
106(1):
247 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Napier, P. Ponka, and D. R. Richardson
Iron trafficking in the mitochondrion: novel pathways revealed by disease
Blood,
March 1, 2005;
105(5):
1867 - 1874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Nie, A. D. Sheftel, S. F. Kim, and P. Ponka
Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis
Blood,
March 1, 2005;
105(5):
2161 - 2167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Campanella, G. Isaya, H. A. O'Neill, P. Santambrogio, A. Cozzi, P. Arosio, and S. Levi
The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast
Hum. Mol. Genet.,
October 1, 2004;
13(19):
2279 - 2288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. PONKA
Hereditary Causes of Disturbed Iron Homeostasis in the Central Nervous System
Ann. N.Y. Acad. Sci.,
March 1, 2004;
1012(1):
267 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |